FDA panel recommends Gilead’s Quad for HIV – Reuters

by Blogburger on May 11, 2012

FDA panel recommends Gilead's Quad for HIV
By David Morgan | WASHINGTON (Reuters) – A US Food and Drug Administration panel of outside experts on Friday recommended the use of Gilead Sciences Inc's Quad pill for untreated HIV patients. The FDA advisory committee voted 13-1 to endorse the
FDA reviews first rapid, take-home test for HIV The Associated Press
FDA Panel Backs Gilead's HIV 'Quad' MedicineWall Street Journal
HIV advocates say Truvada could save livesCBS News
MedPage Today –BusinessWeek
all 1,824 news articles »

Health – Google News

Comments on this entry are closed.

Previous post:

Next post: